GBA1 and Parkinsonism: In the Parkinson Progression Markers Initiative (PPMI) biomarkers of altered sphingolipid metabolism were invariably higher in the CSF of PD patients with increased values in patients carrying GBA mutations in comparison to patients GBA wildtype [175,176].